& Women's Sexual Health
& Women's Sexual Health
The She Shot is a procedure that utilizes the power of Platelet Rich Plasma (PRP), an injection therapy used in Regenerative Medicine. This treatment can help women control their flow of urine by tightening the tissues of the urinary tract and vaginal area as well as rebuilding the body's own natural collagen.
The urethra to prevent urinary leakage
The labia for a “lift” effect
The clitoris for increased sensitivity
The G-spot for improved orgasms
It is a One Visit Procedure
Reduces or eliminates urinary leakage
Improved vaginal dryness
Effects often last a year or more
Improved health of sexual organs
Only requires a local anesthetic
Contributes to better orgasms
Procedure takes less than one hour
Safe with virtually no side effects
*HSA and FSA eligible
EDUCATION IS EMPOWERMENT
Peripheral neuropathy is a condition often associated with diabetes (about 60% of patients who suffer from diabetes will develop peripheral neuropathy) but it can also be caused by chemotherapy treatments, autoimmune disorders, nerve impingement, nutritional imbalances, infections, and can even be hereditary. The nerve disorder currently affects about 20 million people in the United States, and with the rising numbers of the above-mentioned conditions, that number is estimated to grow rapidly.
Various patients experience peripheral neuropathy differently. For some individuals, the pain may come and go, while for others, it's constant. Depending on the condition of the nerve, one can also experience tingling, numbing, a freezing sensation and or tickling in the extremities. In addition, neuropathy can also damage the brain’s capability to communicate properly with various regions of the body leading to difficulty walking, especially on uneven surfaces. As the condition worsens, individuals may experience coordination and balance loss along with a freezing pain, muscle weakness, or extreme sensitivity to touch.
What many don’t know is that these damaged nerves that are causing the neuropathy symptoms can be repaired. Peripheral nerves can and do regenerate, the issue for most suffering from neuropathy is that the nerves are being damaged fast than they can repair and the condition gets progressively worse. The key to successfully reversing neuropathy is two-fold: one, address the underlying factors that are damaging the nerves (ex. get the type II diabetes under control) and two, help speed up the regenerative process.
We are able now to accelerate nerve regeneration using Electric Cell Signaling (ECS); a device that promotes the dilation of blood vessels, increases blood flow, and reduces inflammation to repair and regenerate the nerve cells for healing. Using electronic signals or electrotherapy at specific wavelengths, the ECS system breaks the pain signals that pass in the nerves cells (also called axons) . As a result, they stop relaying the pain stimulus, giving you relief. Essentially, the ECS device reprograms the nerves to “forget” the pain patterns they have learned. It is used in combination with a series of injections of a proprietary blend of vitamins. The injections enhance the treatment by giving the nerves and tissues the building blocks they need to restore and repair.
Sanexas is the only ECS device published in multiple medical journals and used in clinical research proving the ability to reverse painful peripheral neuropathy and regenerate nerves. The average person will start noticing changes after 6-15 treatments. Some notice changes earlier or later depending on the area receiving treatment and level of damage, but it is necessary to receive a series (multiple treatments) for the treatment to be effective. While the results of Sanexas treatments have proven to be extremely successful, there is no guarantee. Neuropathy symptoms will be more likely to improve and less likely to return if patient makes the recommended lifestyle changes in conjunction with treatment.
When ECS is used in combination with adjunct therapies addressing the root cause or secondary conditions, the results can be quite dramatic. Especially in cases of neuropathy associated with diabetes, addressing the nutritional components of cellular health have had remarkable benefits for the pain symptoms and overall well-being. Type II diabetes, while having a genetic component, responds greatly to changes in diet and nutrition. As the diabetic condition improves, so do the secondary health issues such as neuropathy.
Corrective Chiropractic Care has been an effective adjunct treatment for peripheral neuropathy because it can target pinched nerves and helps to promote a healthy nervous system. Proper diagnostic exams must be performed to determine an appropriate course of treatment, but when used in conjunction with the above treatments, patient satisfaction ratings have been astounding.
Early diagnosis and treatment may reduce the severity of the motor and sensory nerve damage, vastly reducing treatment and recovery times. In addition, the pain symptoms associated with peripheral neuropathy can be an indication of other health conditions that need to be evaluated carefully. Getting a full diagnostic work up is highly recommended for those seeking long lasting relief.
Many of those suffering with neuropathy have lost hope when their pain medications (gabapentin being the most common) offer little to no relief and doctors have told them there is nothing else that they can do. ECS has been able to give these sufferers not only relief, but for so many, their independence back!
Disclaimer: None of the statements on this page are intended to make any claims about HTT, but instead describe many of the basic functions of native human tissue. Per FDA Guidance, it is not necessary for the HCT/P in the recipient to perform all of the basic functions it performed in the donor in order to meet the definition of homologous use. Human Tissue Therapy, as we use that term on this website, are minimally manipulated cells and tissues intended for homologous use only. None of the mentioned statements have been evaluated by the FDA. As defined in 21 CFR 1271.3(c), homologous use means the repair, reconstruction, replacement, or supplementation of a recipient’s cells or tissues with an HTT/P that performs the same basic function or functions in the recipient as in the donor. Human Tissue Therapies are not intended to diagnose, treat, cure or prevent any disease including COVID-19.